Loading viewer...
earnings
Format: PDF earnings
Ambu reports Q2 and H1 2024/25 results with 15.4% organic revenue growth and 15.2% EBIT margin expansion. The company achieved a strong start for its Ambu® SureLight™ Connect launch in pulmonology and continued positive momentum in urology. Management confirms current FY 2024/25 financial guidance.
investor_presentation
13 Pages
earnings
19 Pages
TransAlta
Honeywell Q1 2023 Earnings Release - April 27
earningsearnings
24 Pages
Honeywell International Inc.
The Trade Desk Q4 FY2018 Investor Presentation
earningsearnings
39 Pages
The Trade Desk, Inc.